Publication Name	World Journal of Virology
Manuscript ID	14767
Country	United States

Received	2014-10-23 08:37
Peer-Review Started	2014-10-23 18:00
To Make the First Decision	2014-11-14 17:40
Return for Revision	2014-11-17 18:59
Revised	2014-12-04 00:10
Second Decision	2015-02-04 11:53
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2015-02-11 16:19
Articles in Press	2015-02-11 16:19
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2015-04-17 17:26
Publish the Manuscript Online	2015-04-30 17:58

ISSN	2220-3249 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Infectious Diseases
Manuscript Type	Minireviews
Article Title	Debunking the myths perpetuating low implementation of isoniazid preventive therapy amongst human immunodeficiency virus-infected persons
Manuscript Source	Invited Manuscript
All Author List	Christopher Akolo, Florence Bada, Evaezi Okpokoro, Ogochukwu Nwanne, Sharon Iziduh, Eno Usoroh, Taofeekat Ali, Vivian Ibeziako, Olanrewaju Oladimeji and Michael Odo
Funding Agency and Grant Number
Corresponding Author	Christopher Akolo, MBBS, MSc, FWACP, Senior Technical Advisor HIV/TB, Population Services International, 1120 19th Street, N.W. Ste. 600, Washington, DC 20036, United States. akolochris@yahoo.com
Key Words	Human immunodeficiency virus; Isoniazid preventive therapy; Tuberculosis; Chemoprophylaxis
Core Tip	To better inform healthcare providers, policy makers and human immunodeficiency virus-infected persons about isoniazid preventive therapy (IPT), this article summarizes the existing evidence in support of IPT including recommendations for scale-up of implementation globally.
Publish Date	2015-04-30 17:58
Citation	Akolo C, Bada F, Okpokoro E, Nwanne O, Iziduh S, Usoroh E, Ali T, Ibeziako V, Oladimeji O, Odo M. Debunking the myths perpetuating low implementation of isoniazid preventive therapy amongst human immunodeficiency virus-infected persons. World J Virol 2015; 4(2): 105-112
URL	http://www.wjgnet.com/2220-3249/full/v4/i2/105.htm
DOI	http://dx.doi.org/10.5501/wjv.v4.i2.105

Full Article (PDF)	WJV-4-105.pdf
Full Article (Word)	WJV-4-105.doc
Manuscript File	14767-Review.docx
Answering Reviewers	14767-Answering reviewers.pdf
Conflict-of-Interest Disclosure Form	14767-Conflict-of-interest statement.pdf
Copyright License Agreement	14767-Copyright assignment.pdf
Peer-review Report	14767-Peer-review(s).pdf
Scientific Misconduct Check	14767-Scientific misconduct check.pdf
Scientific Editor Work List	14767-Scientific editor work list.pdf